Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Strategic Partnership Signals New Age of Stratified Medicine

Published: Thursday, May 02, 2013
Last Updated: Thursday, May 02, 2013
Bookmark and Share
Aridhia and Pivotal™ collaborating on revolutionary solutions for chronic disease management.

Health and biomedical informatics company Aridhia today announced a strategic partnership with Pivotal, the company setting the new standard for Enterprise PaaS, to create a new technology platform capable of revolutionising the management of chronic health conditions such as cancer, diabetes and cardiovascular disease.

Developing on the Pivotal One™ platform, the companies will work together to provide the international healthcare, life and biomedical science markets with applications and services that enable the rapid, sophisticated analysis of massive amounts of clinical, patient, imaging and genomic data and provide a comprehensive picture of factors affecting each patient’s treatment and healthcare outcomes.

The collaboration will enable clinicians and researchers to gain fresh insights into correlations between patient, clinical and genomic data and usher in a new age of ‘stratified medicine’, offering improved, personalised treatments tailored to the genetics of individual patients.

As chronic diseases such as cancer, diabetes, respiratory and cardiovascular disease become increasingly prevalent worldwide, Aridhia’s CEO and Chairman, Dr David Sibbald, believes healthcare organisations will rely more on real-time data analysis and disease management services to enhance service delivery, stratify patient risk and improve clinical outcomes.

“Chronic diseases are the leading cause of morbidity and mortality in the world.  There is an urgent clinical and economic need to manage those conditions more effectively, which is why we are excited to have the opportunity to join forces with Pivotal.  Medicine and biology are rapidly becoming information sciences and this collaboration will not only allow us to enhance our existing biomedical informatics solutions, but will also deliver the advanced informatics services required for the development of stratified medicine.

“An individual’s genetic profile can have a significant impact on the choice and effectiveness of their treatment plan. Our approach will enable healthcare professionals to treat patients with all the necessary information available at the point of care, presenting data in a way that supports safe, effective and patient-centred health care.

“By combining our health and biomedical informatics expertise with Pivotal’s outstanding capability in real-time, high-capacity analytics and scalability, we are a step closer to our goal of becoming a world leader in the detailed analysis of clinical and scientific information required for the personalised treatment pathways of the future,” says Dr Sibbald.

Chris Roche, Chief Technology Officer in Europe, Middle East and Africa at Pivotal, agrees that the new collaboration has the potential to produce improvements in the treatment and outcomes of tens of millions of people living with chronic disease worldwide. Roche says: “Health and biomedical solutions utilising the latest analytical techniques can enable easier identification of the risks of chronic disease and ensure patient management is as effective as possible. With healthcare budgets being squeezed, and chronic disease a growing problem in an ageing population across the world, the application of advanced analytics aligned to clinical practice will become increasingly important. Applied in this way, the right technology has the potential to assist with the proper targeting of resources, and the effective mitigation of the effects of diabetes, cancer, respiratory and cardiovascular disease worldwide.”

Roche continued “Aridhia has successfully built a team of clinicians, life scientists, data scientists and software developers to tackle simultaneously the complexities of disease management within ever-changing healthcare systems. This multidisciplinary combination of clinical and informatics domain expertise is very rare and we’re extremely pleased to be partnering and collaborating within this field.

With the prohibitive cost of sequencing an individual’s genome continuing to fall rapidly, stratified medicine is widely predicted to be a huge growth area for healthcare providers over the next decade.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!